Maggie is a senior editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Dr Todd Schlesinger: Treatment for Early-Stage Melanomas Can Be Safely Delayed During the Pandemic
We can safely delay excising in situ and early-stage melanomas while managing our patients’ care, noted Todd Schlesinger, MD, FAAD, director, Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas.
Diagnose, Monitor, Treat: How AI’s 3-Pronged Approach Can Help to Propel Progress in MS
Using artificial intelligence (AI) effectively may help to revolutionize the diagnosis, monitoring, and treatment of multiple sclerosis (MS), as well as optimizing understanding of the immune-mediated disease.
SisterLove Inc Founder Dázon Dixon Diallo on Why She Took on the Anti-AIDS Establishment
SisterLove Inc is a 32-year-old sexual reproductive health rights and justice organization with a core focus on HIV and sexually transmitted infections at the intersection of other challenges to women's sexual reproductive health and well-being.
Dr Mariana Garcia: We Cannot Overlook the Influence of Psychological Distress on Our Patients
The pandemic has exacerbated not only cardiovascular care, but also the mental health of patients, noted Mariana Garcia, MD, cardiology fellow in the Academic Clinical Investigator Pathway at Emory University and member of T32, Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health (METRIC).
Neurocognitive Decline Seen Among Binge Drinkers Living With HIV
The cumulative effects of binge drinking and HIV on neurocognitive functioning were investigated among 4 groups of patients in this recent study from researchers at San Diego State University and the University of California San Diego.
Brain Inflammation May Result From Psychologic Stress in Persons Living With HIV
People living with HIV have known greater rates of stroke, but the reason for that risk was the focus of an abstract presented last week at IAS 2021, this year's virtual annual meeting of the International AIDS Society, which took place July 18 to 21.
Dr Clyde Yancy: We Must Continue to Explore Why SGLT2 Inhibitors Are Effective in HF
We do not yet know the exact mechanism of action of sodium glucose co-transporter-2 (SGLT2) inhibitors in heart failure (HF), but there are many exciting pssibilities, stated Clyde W. Yancy, MD, MSc, of Northwestern University’s Feinberg School of Medicine.
Dr Helen Bygrave: Differentiated HIV Service Delivery Is a Client-Centered Approach
Providers need to put themselves in their patients' shoes and think about how they would like to receive services, emphasized Helen Bygrave, MD, chronic diseases advisor for the Médecins Sans Frontières’ (Doctors Without Borders) Access Campaign.
Novel Modeling Approach Improves Health Equity in HIV
An abstract presented at IAS 2021, this year's virtual annual meeting of the International AIDS Society, addressed health care disparities that persist among persons living with HIV, with the ultimate goal being to improve health equity for this patient population.
Dr Mikhail N. Kosiborod: DARE-19 Results Do Not Support SGLT2 Treatment Discontinuation
Patients should continue to be monitored while on treatment with SGLT2 inhibitors if they are being treated for comorbid type 2 diabetes and heart failure, emphasized Mikhail N. Kosiborod, MD, cardiologist, vice president of Research at Saint Luke's Health System.
Dr Todd Schlesinger: Surgical Decisions for Skin Cancer Are Multimodal
The characteristics of the tumor and the presence of surgical fatigue can help determine patients’ candidacy for skin cancer surgery, explained Todd Schlesinger, MD, FAAD, director, Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas.
Dr Perry N. Halkitis: To Eradicate HIV, We Must Deal With Structural Inequities
By 2020, UNAIDS had hoped to meet the 90-90-90 goal it originally set in 2014: to have 90% of people living with HIV know their status, 90% be on antiretroviral therapy (ART), and 90% have achieved viral suppression. The world fell short of meeting that goal, with just 81% knowing their positive status, two-thirds on ART, and 59% being virally suppressed.
Early Intensive DMT Use May Prevent Greater Long-term Disability in RRMS
Early intensive treatment was more efficacious at slowing disease accumulation in patients with relapsing-remitting multiple sclerosis (RRMS) vs initiating therapy with a moderate-efficacy disease-modifying treatment (DMT) prior to switching to a higher-efficacy DMT.
Increased Sudden Cardiac Death, Myocardial Fibrosis Seen in Persons Living With HIV
Compared with individuals without known HIV infection, persons living with HIV had higher rates of sudden cardiac death and increased interstitial myocardial fibrosis in a new New England Journal of Medicine study.